SCHEMBL5577905

SCHEMBL5577905

Cc1ccc(C(=O)NCc2cccc(N3CCN(CC=Cc4ccc(N(C)C)cc4)CC3)c2)c(C)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANXA2 P07355 3/20 0.43
S100A10 P60903 3/20 0.43
KDM4E B2RXH2 5/20 0.42
ALDH1A1 P00352 5/20 0.42
MAPT P10636 3/20 0.42
HPGD P15428 2/20 0.42
HSD17B10 Q99714 2/20 0.42
GLA P06280 1/20 0.42
ALOX15 P16050 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HTT P42858 2/20 0.41
NSD2 O96028 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
HDAC3 O15379 1/20 0.38
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
HDAC7 Q8WUI4 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5577900 1.00 ANXA2 (0.43) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577310 0.94 ANXA2 (0.43) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577307 0.94 ANXA2 (0.43) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577686 0.92 ALDH1A1 (0.46) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577687 0.92 ALDH1A1 (0.46) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577265 0.91 ALDH1A1 (0.50) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577263 0.91 ALDH1A1 (0.50) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577333 0.88 HSD17B10 (0.48) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577331 0.88 HSD17B10 (0.48) ANXA2S100A10KDM4EALDH1A1MAPT
SCHEMBL5577600 0.85 KDM4E (0.48) KDM4EALDH1A1MAPTHPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-02-22 US disclosed
EP-1616862-A1 NITROGENOUS HETEROCYCLIC COMPOUND AND USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2006-01-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070043079-A1 Heterocyclic compound containing nitrogen atom and use thereof HLA-DRB1, MIF, HLA-C ANXA2 991/4885S100A10 1006/4885KDM4E 4213/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.